À¯º´·ü (Prevalence) : ÀÏÁ¤ ½ÃÁ¡ ¶Ç´Â ÀÏÁ¤ ±â°£ µ¿¾ÈÀÇ Àα¸ Áß Á¸ÀçÇϴ ȯÀÚÀÇ ºñÀ²
= ƯÁ¤ ½ÃÁ¡¿¡¼ÀÇ È¯ÀÚ ¼ö
¾î´À ½ÃÁ¡ÀÇ Àα¸
¹ßº´·ü (Incidence) : ±× Áúº´ÀÇ ¿øÀÎ ¿äÀο¡ Á¢ÃË ¶Ç´Â Æø·ÎµÈ »ç¶÷µéÀ» °¨¼ö¼º Àα¸·Î ÇÏ¿© ±¸ÇÑ ¹ß»ý·ü
= ¿¬°£ ¹ßº´ÀÚ ¼ö
À§Çè¿¡ Æø·ÎµÈ Àα¸
¹ß»ý·ü: ÀÏÁ¤±â°£ µ¿¾È ¹ß»ýÇÑ »õ·Î¿î ȯÀÚ ¼ö
= ¾î´À ±â°£ÀÇ È¯ÀÚ ¹ß»ý ¼ö
±× Áö¿ªÀÇ Àα¸
Ä¡¸í·ü: º´¿øÃ¼ÀÇ µ¶¼ºÀÌ ³ô°í ±× Áúº´¿¡ ´ëÇÑ ¸é¿ª·Â ¹× ÀúÇ×·ÂÀº ³·À¸¸ç Àα¸ Áý´ÜÀÇ °Ç°µµ°¡ ³·À½
= ƯÁ¤ Áúº´À¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö
ƯÀý ÁúȯÀÇ È¯ÀÚ ¼ö
[Ãâó] À¯º´·ü, ¹ßº´·ü, ¹ß»ý·ü, Ä¡¸í·ü|ÀÛ¼ºÀÚ khi798
http://surveillance.cancer.gov/prevalence/
• Limited-Duration Prevalence represents the proportion of people alive on a certain day who had a diagnosis of the disease within the past x years.
• Complete Prevalence represents the proportion of people alive on a certain day who previously had a diagnosis of the disease, regardless of how long ago the diagnosis was, or if the patient is still under treatment or is considered cured.
|
|